Loading...

← Back to Leaderboard

Karl Claxton

Institution: University of York

Primary Field: Health (weighted toward more recent publications)

Homepage: http://www.york.ac.uk/che/staff/research/karl-claxton/

First Publication: 1999

Most Recent: 2018

RePEc ID: pcl81 ↗

Publication Scores

Scores use coauthorship adjustment: α/n credit per paper, where n = number of authors. α = 2.02: calibrated so average adjusted count equals average raw count (a zero-sum adjustment).

Period S (4x) A (2x) B (1x) C (½x) Total Percentile
Last 5 Years 0.00 0.00 0.00 0.00 0.00 -
Last 10 Years 0.00 0.00 3.90 0.00 3.90 63%
All Time 0.00 0.00 20.28 0.00 20.28 94%

Publication Statistics

Raw Publications 22
Coauthorship-Adjusted Count 20.30

Publications (22)

Year Article Journal Tier Authors
2018 Social value and individual choice: The value of a choice‐based decision‐making process in a collectively funded health system Health Economics B 4
2018 The impact of NHS expenditure on health outcomes in England: Alternative approaches to identification in all‐cause and disease specific models of mortality Health Economics B 3
2018 Comment: Positive tails and normative dogs Health Economics B 1
2018 How to design the cost‐effectiveness appraisal process of new healthcare technologies to maximise population health: A conceptual framework Health Economics B 4
2016 Unrelated Future Costs and Unrelated Future Benefits: Reflections on NICE Guide to the Methods of Technology Appraisal Health Economics B 10
2015 Causes for Concern: Is Nice Failing to Uphold Its Responsibilities to All Nhs Patients? Health Economics B 4
2012 Budget allocation and the revealed social rate of time preference for health Health Economics B 2
2011 Discounting and decision making in the economic evaluation of health‐care technologies Health Economics B 5
2011 Dangerous omissions: the consequences of ignoring decision uncertainty Health Economics B 4
2010 Budgetary policies and available actions: A generalisation of decision rules for allocation and research decisions Journal of Health Economics B 4
2010 Sins of omission and obfuscation: IQWIG's guidelines on economic evaluation methods Health Economics B 2
2007 In recognition of Anthony J. Culyer Journal of Health Economics B 1
2007 Oft, Vbp: Qed? Health Economics B 1
2006 Discounting and cost‐effectiveness in NICE – stepping back to sort out a confusion Health Economics B 8
2006 Whither trial‐based economic evaluation for health care decision making? Health Economics B 4
2006 Evidence synthesis, parameter correlation and probabilistic sensitivity analysis Health Economics B 3
2005 Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra Health Economics B 8
2001 Representing uncertainty: the role of cost‐effectiveness acceptability curves Health Economics B 3
2001 A dynamic programming approach to the efficient design of clinical trials Journal of Health Economics B 2
1999 The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies Journal of Health Economics B 1
1999 Redefining the analytical approach to pharmacoeconomics Health Economics B 2
1999 Bayesian approaches to the value of information: implications for the regulation of new pharmaceuticals Health Economics B 1